Aug 28 (Reuters) - Diagnos Inc ADK.V
* Diagnos announces restatement of March 31, 2017 financial statements which resulted in a decrease in expenses of $2,491,096
* Diagnos - restatement resulted in a comprehensive loss of $2.8 million, basic diluted comprehensive loss per share of $0.02 for year ended March 31, 2017